Results 271 to 280 of about 6,066,361 (406)
Exosomes as Emerging Therapeutic Strategies in Primary Osteoporosis: A Narrative Review. [PDF]
Chen G, Li H, Chen R, Chen G.
europepmc +1 more source
Fracture of Hyoid Bone in a Man Aged 56 (“Garrotter's Throat”)
H. J. Davis
openalex +1 more source
This review highlights recent advances in engineering artificial antigen‐presenting cells (aAPCs) as alternatives to dendritic cells for T cell expansion. Key design principles inspired by the immunological synapse are discussed, with emphasis on strategies for polyclonal and antigen‐specific T cell expansion.
Nguyen Thi Nguyen, Yu Seok Youn
wiley +1 more source
Inter-implant distance correlated to different preparation protocol on cortical bone: an animal study. [PDF]
Toia M +7 more
europepmc +1 more source
Biofabrication aims at providing innovative technologies and tools for the fabrication of tissue‐like constructs for tissue engineering and regenerative medicine applications. By integrating multiple biofabrication technologies, such as 3D (bio) printing with fiber fabrication methods, it would be more realistic to reconstruct native tissue's ...
Waseem Kitana +2 more
wiley +1 more source
The Role of GPR39 in Regulating Osteoblast Function, Bone Matrix Quality, and Gender-Specific Bone Homeostasis. [PDF]
Chaterjee B +8 more
europepmc +1 more source
Treatment of Ununited Fractures by Bone Grafting without Resection of the Bone Ends
H. Jackson Burrows
openalex +1 more source
Versatile Cell Penetrating Peptide for Multimodal CRISPR Gene Editing in Primary Stem Cells
CRISPR machinery in diverse molecular formats (DNA, RNA, and ribonucleic protein) is complexed into nanoparticles with the cell‐friendly arginine‐alanine‐leucine‐alanine (RALA) cell‐penetrating peptide. Nanoparticles are delivered to primary mesenchymal stem cells ex vivo or locally in vivo to facilitate multimodal CRISPR gene editing. This RALA‐CRISPR
Joshua P. Graham +9 more
wiley +1 more source
Regulating osteogenic differentiation of bone marrow mesenchymal stem cells by mTORC1 signaling pathway inhibits bone defect repair in mice. [PDF]
Huang Z +7 more
europepmc +1 more source

